Accession Number : ADA256959


Title :   Nifedipine for Treatment of High Altitude Pulmonary Edema.


Descriptive Note : Final rept. 1 May 91-30 Sep 92,


Corporate Author : DENALI MEDICAL RESEARCH PROJECT ANCHORAGE AK


Personal Author(s) : Hackett, Peter H ; Roach, R C ; Greene, E R ; Levine, B


Full Text : https://apps.dtic.mil/dtic/tr/fulltext/u2/a256959.pdf


Report Date : 30 Jul 1992


Pagination or Media Count : 30


Abstract : In 12 subjects with high altitude pulmonary edema, we studied the effects of 10mg nifedipine on pulmonary and systemic hemodynamics and arterial oxygen saturation. In five of these, repeated dosing was done over 3 hours and spirometry and clinical HAPE scores were also obtained. A single 10mg nifedipine dose lowered pulmonary vascular resistance and pulmonary arterial pressures, as well as systemic arterial pressure and increased SaO2%. Multiple dosing sustained the drug effect, but with a smaller increase SaO2% Clinical scores improved slightly, and within 3 hours there was no consistent effect on spirometry. In addition, we undertook a survey of pulmonary hypertension (PHT) at high altitude, and surprisingly discovered excessive PHT in asymptomatic individuals. We conclude that nifedipine vasodilates the pulmonary bed in persons with HAPE, and that this appears to be beneficial, although short-term improvement was minimal. Since asymptomatic PHT is common, factors other than PHT are critical in HAPE pathogenesis, and by extension, could be important in prevention and treatment.


Descriptors :   *HIGH ALTITUDE , *PULMONARY EDEMA , MEASUREMENT , RESISTANCE , VOLUNTEERS , SATURATION , BAROMETRIC PRESSURE , ALTITUDE , PATHOGENESIS , PULMONARY HYPERTENSION , SPIROMETRY , EDEMA , ADDITION , HYPERTENSION , PREVENTION , DRUGS , OXYGEN , SURVEYS , ILLNESS , PRESSURE


Subject Categories : Medicine and Medical Research
      Stress Physiology


Distribution Statement : APPROVED FOR PUBLIC RELEASE